As of 4:00pm ET
| +0.35 / +1.29%|
The 10 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 18.50, with a high estimate of 34.00 and a low estimate of 15.00. The median estimate represents a -32.85% decrease from the last price of 27.55.
The current consensus among 11 polled investment analysts is to Hold stock in Acorda Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.